|
Market Closed -
Nasdaq Stockholm
17:00:00 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.3755 SEK | +1.08% |
|
-11.75% | -54.70% |
| 10-21 | Alzinova Finalizes US Trial Sites for Mid-stage Alzheimer's Disease Vaccine Study | MT |
| 10-21 | Alzinova selects seven U.S. trial sites ahead of phase IIa study | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- ALZ Stock
- Charts Alzinova AB
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
